Danone S.A. (BN.PA)
Paris, FR
Danone S.A. is a major company within the food and beverage industry, conducting its operations across various global regions including Europe, North America (Noram), Latin America, Asia Pacific, Africa, and the Middle East. The company's business is organized into three principal segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. Under its Essential Dairy & Plant-Based division, Danone manufactures and distributes a broad array of products. This range includes yogurts, diverse milk products, coffee creamers, a variety of drinks and beverages, plant-based alternatives, ice creams, desserts, and powdered nutritional protein items. These are sold under proprietary brands such as Actimel, Activia, Alpro, Danette, Danio, and Danonino, as well as licensed brands including International Delight, Dunkin' Donuts, and Bailey's. The Specialized Nutrition segment focuses on providing tailored nutritional offerings. This encompasses products developed for pregnant and breastfeeding mothers, infants, and young children, marketed under names like Aptamil, Nutrilon, Gallia, Cow & Gate, Blédina, Bebelac, Olvarit, and Happy Family Organics. Additionally, this segment extends to medical nutrition, featuring tube feeding formulas (e.g., Nutrison), oral nutritional supplements (e.g., Fortimel, NutriDrink), and specialized hypoallergenic products for children with allergies (e.g., Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo). Within the Waters segment, Danone offers a portfolio of bottled water products, some of which are enhanced with natural fruit extracts, fruit juice, and vitamins. Key brands in this category include evian, Volvic, Aqua, Mizone, Bonafont, Villavicencio, Villa del Sur, Hayat, Sirma, Fontvella, Lanjarón, Salus, Aqua d'Or, and Zywiec Zdroj. Danone distributes its wide selection of products through multiple channels. These include large retail chains, traditional market outlets, convenience stores, healthcare settings such like hospitals, clinics, and pharmacies, and increasingly, through e-commerce platforms. Incorporated in 1899, the company was initially known as Groupe Danone before officially changing its name to Danone S.A. in April 2009. Its corporate headquarters are situated in Paris, France.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.49% | -1.30% | -8.69% | -16.11% | -20.86% | -20.63% | -19.01% | +9.37% | +4.53% | -4.12% | +1,898.03% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 8 | +1 |
| Hold | 9 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | -1 |
-
Revenue growth Packaged Foods: +4.4%-0.3% Q4'25: +0.7% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%-9.9% Q4'25: +466.7% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+7.6% Q4'25: +11.6% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+11.1% ★ Q4'25: +9.5% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+8.4% ★ Q4'25: +13.7% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%+0.1% Q4'25: +0.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×4.98× Q4'25: 5.85× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2001 actual |
Dec 2002 actual |
Dec 2003 actual |
Dec 2004 actual |
Dec 2005 actual |
Dec 2006 actual |
Dec 2007 actual |
Dec 2008 actual |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 18 Rev. Ana. 14 EPS Ana. |
Dec 2027 18 Rev. Ana. 14 EPS Ana. |
Dec 2028 15 Rev. Ana. 8 EPS Ana. |
Dec 2029 11 Rev. Ana. 6 EPS Ana. |
Dec 2030 7 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
14.50B
est: 14.85B (-2.4%)
|
13.57B
est: 14.03B (-3.3%)
|
13.11B
est: 13.57B (-3.4%)
|
12.27B
est: 13.87B (-11.5%)
|
13.02B
est: 13.12B (-0.7%)
|
12.07B
est: 14.33B (-15.8%)
|
12.78B
est: 13.99B (-8.7%)
|
15.22B
est: 15.56B (-2.2%)
|
14.98B
est: 15.19B (-1.4%)
|
17.01B
est: 17.07B (-0.3%)
|
19.32B
est: 19.53B (-1.1%)
|
20.87B
est: 21.06B (-0.9%)
|
21.30B
est: 21.78B (-2.2%)
|
21.14B
est: 21.45B (-1.4%)
|
22.41B
est: 22.38B (+0.1%)
|
21.94B
est: 21.95B (0.0%)
|
24.81B
est: 24.76B (+0.2%)
|
24.65B
est: 24.68B (-0.1%)
|
25.29B
est: 25.25B (+0.1%)
|
23.62B
est: 23.71B (-0.4%)
|
24.28B
est: 24.02B (+1.1%)
|
27.66B
est: 27.56B (+0.4%)
|
27.62B
est: 27.21B (+1.5%)
|
27.38B
est: 27.16B (+0.8%)
|
27.28B
est: 27.33B (-0.2%)
|
28.05B
27.62B – 28.82B
+2.6% YoY
|
29.19B
28.28B – 29.88B
+4.1% YoY
|
30.32B
30.30B – 30.34B
+3.9% YoY
|
31.72B
30.99B – 32.54B
+4.6% YoY
|
34.38B
33.58B – 35.26B
+8.4% YoY
|
| EBITDA |
2.39B
est: 2.03B (+18.0%)
|
2.31B
est: 1.08B (+113.9%)
|
2.20B
est: 2.31B (-4.6%)
|
2.20B
est: 1.90B (+15.9%)
|
2.26B
est: 1.19B (+89.8%)
|
2.20B
est: 2.53B (-12.9%)
|
2.10B
est: 2.12B (-1.0%)
|
2.63B
est: 5.38B (-51.1%)
|
2.91B
est: 1.80B (+61.9%)
|
2.52B
est: 2.32B (+8.3%)
|
3.32B
est: 3.32B (+0.1%)
|
3.36B
est: 2.98B (+12.9%)
|
3.47B
est: 3.00B (+15.7%)
|
3.36B
est: 2.50B (+34.1%)
|
3.73B
est: 2.64B (+41.5%)
|
3.81B
est: 2.92B (+30.7%)
|
4.44B
est: 3.57B (+24.1%)
|
4.52B
est: 3.98B (+13.5%)
|
5.09B
est: 4.52B (+12.8%)
|
4.42B
est: 3.73B (+18.4%)
|
4.15B
est: 3.86B (+7.3%)
|
4.25B
est: 3.97B (+7.2%)
|
4.75B
est: 4.17B (+13.8%)
|
4.36B
est: 4.19B (+4.1%)
|
3.03B
est: 4.19B (-27.6%)
|
4.30B
4.24B – 4.42B
+2.6% YoY
|
4.48B
4.34B – 4.58B
+4.1% YoY
|
4.65B
4.65B – 4.66B
+3.9% YoY
|
4.87B
4.75B – 4.99B
+4.6% YoY
|
5.27B
5.15B – 5.41B
+8.4% YoY
|
| EBIT |
1.61B
est: 1.72B (-6.5%)
|
1.59B
est: 804.70M (+97.8%)
|
1.60B
est: 1.98B (-19.1%)
|
1.72B
est: 1.58B (+8.9%)
|
1.79B
est: 1.51B (+17.9%)
|
1.71B
est: 1.86B (-8.3%)
|
1.68B
est: 1.83B (-8.4%)
|
2.10B
est: 1.72B (+22.2%)
|
2.36B
est: 2.14B (+10.6%)
|
2.52B
est: 2.82B (-10.7%)
|
2.68B
est: 2.86B (-6.4%)
|
2.69B
est: 2.94B (-8.6%)
|
2.76B
est: 2.85B (-3.4%)
|
2.65B
est: 2.10B (+26.6%)
|
2.96B
est: 2.27B (+30.3%)
|
3.06B
est: 2.16B (+41.3%)
|
3.59B
est: 3.29B (+9.3%)
|
3.62B
est: 3.67B (-1.4%)
|
3.87B
est: 2.79B (+38.5%)
|
3.33B
est: 3.11B (+7.2%)
|
3.34B
est: 3.22B (+3.7%)
|
3.38B
est: 3.30B (+2.4%)
|
3.49B
est: 3.40B (+2.6%)
|
3.51B
est: 3.49B (+0.6%)
|
3.03B
est: 3.42B (-11.2%)
|
3.51B
3.46B – 3.61B
+2.6% YoY
|
3.65B
3.54B – 3.74B
+4.1% YoY
|
3.79B
3.79B – 3.80B
+3.9% YoY
|
3.97B
3.88B – 4.07B
+4.6% YoY
|
4.30B
4.20B – 4.41B
+8.4% YoY
|
| Net Income |
132.62M
est: 790.50M (-83.2%)
|
1.28B
est: 124.67M (+930.4%)
|
837.70M
est: 1.24B (-32.5%)
|
449.00M
est: 857.35M (-47.6%)
|
1.46B
est: 299.94M (+388.1%)
|
1.35B
est: 1.60B (-15.4%)
|
4.18B
est: 1.32B (+216.3%)
|
1.31B
est: 4.65B (-71.7%)
|
1.36B
est: 1.28B (+6.1%)
|
1.88B
est: 1.53B (+22.7%)
|
1.67B
est: 2.14B (-21.9%)
|
1.67B
est: 1.80B (-7.2%)
|
1.42B
est: 1.74B (-18.1%)
|
1.12B
est: 1.40B (-20.1%)
|
1.28B
est: 1.18B (+8.3%)
|
1.72B
est: 1.26B (+36.6%)
|
2.45B
est: 1.94B (+26.0%)
|
2.35B
est: 2.44B (-3.6%)
|
1.93B
est: 2.39B (-19.3%)
|
1.96B
est: 1.85B (+5.7%)
|
1.92B
est: 1.92B (+0.4%)
|
959.00M
est: 1.30B (-26.4%)
|
881.00M
est: 1.00B (-12.2%)
|
2.02B
est: 2.30B (-12.0%)
|
1.82B
est: 2.35B (-22.4%)
|
2.36B
2.30B – 2.62B
+0.3% YoY
|
2.53B
2.48B – 2.85B
+7.4% YoY
|
2.95B
2.77B – 3.14B
+16.6% YoY
|
3.25B
3.15B – 3.36B
+10.1% YoY
|
3.75B
3.64B – 3.88B
+15.5% YoY
|
| SGA |
5.33B
est: 5.92B (-10.1%)
|
5.14B
est: 5.02B (+2.3%)
|
5.14B
est: 4.97B (+3.6%)
|
4.08B
est: 5.27B (-22.4%)
|
4.35B
est: 5.01B (-13.1%)
|
4.05B
est: 4.75B (-14.7%)
|
4.44B
est: 4.54B (-2.3%)
|
5.52B
est: 4.94B (+11.7%)
|
5.60B
est: 5.37B (+4.3%)
|
4.66B
est: 6.25B (-25.4%)
|
6.68B
est: 7.05B (-5.2%)
|
7.22B
est: 7.32B (-1.3%)
|
7.15B
est: 7.63B (-6.2%)
|
6.97B
est: 7.14B (-2.3%)
|
7.64B
est: 7.55B (+1.2%)
|
7.59B
est: 7.72B (-1.7%)
|
8.08B
est: 8.80B (-8.1%)
|
8.03B
est: 8.24B (-2.6%)
|
8.16B
est: 8.22B (-0.7%)
|
7.65B
est: 7.83B (-2.3%)
|
7.84B
est: 8.11B (-3.2%)
|
8.93B
est: 8.33B (+7.3%)
|
9.04B
est: 9.09B (-0.6%)
|
9.50B
est: 9.24B (+2.9%)
|
9.56B
est: 9.13B (+4.7%)
|
9.37B
9.23B – 9.63B
+2.6% YoY
|
9.75B
9.45B – 9.98B
+4.1% YoY
|
10.13B
10.12B – 10.14B
+3.9% YoY
|
10.60B
10.35B – 10.87B
+4.6% YoY
|
11.49B
11.22B – 11.78B
+8.4% YoY
|
| EPS |
0.24
est: 1.30 (-81.6%)
|
2.43
est: 1.63 (+49.0%)
|
1.65
est: 1.55 (+6.3%)
|
0.63
est: 1.73 (-63.5%)
|
2.98
est: 2.09 (+42.5%)
|
2.79
est: 2.38 (+17.3%)
|
8.77
est: 2.51 (+250.0%)
|
2.66
est: 2.69 (-1.2%)
|
2.41
est: 2.65 (-9.2%)
|
3.05
est: 2.79 (+9.4%)
|
2.77
est: 3.00 (-7.7%)
|
2.78
est: 3.11 (-10.5%)
|
2.42
est: 2.90 (-16.4%)
|
1.88
est: 2.69 (-30.0%)
|
2.10
est: 2.89 (-27.3%)
|
2.79
est: 3.07 (-9.2%)
|
3.90
est: 3.42 (+13.9%)
|
3.63
est: 3.55 (+2.2%)
|
2.95
est: 3.83 (-23.0%)
|
2.99
est: 3.25 (-8.0%)
|
2.94
est: 3.29 (-10.6%)
|
1.48
est: 3.35 (-55.8%)
|
1.36
est: 1.56 (-12.9%)
|
3.14
est: 3.55 (-11.7%)
|
2.83
est: 3.78 (-25.1%)
|
3.94
3.57 – 4.05
+4.3% YoY
|
4.23
3.84 – 4.42
+7.5% YoY
|
4.55
4.29 – 4.87
+7.3% YoY
|
5.04
4.89 – 5.21
+10.9% YoY
|
5.82
5.64 – 6.01
+15.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Antoine Bernard de Saint-Affrique | Chief Executive Officer & Non-Independent Director | 4M | male |
| Veronique Penchienati-Bosetta | Group Deputy Chief Executive Officer | 2M | female |
| Henri Bruxelles | President of Americas | — | male |
| Isabelle Esser | Chief HR, R&I, Quality and Food Safety Officer | — | — |
| Jean-Marc Magnaudet | President of Specialized Nutrition | — | male |
| Juergen Esser | Chief Financial, Technology & Data Officer and Group Deputy Chief Executive Officer | — | male |
| Mathilde Rodie | Head of Investor Relations & Sustainable Finance | — | female |
| Pablo E. Perversi | President of Europe, Turkey, Middle East & Africa | — | male |
| Ruchika Sharma | Head of Consumer Marketing | — | female |
| Vikram Agarwal | Chief Operating Officer | — | male |
| Bruno Chevot | President of Asia-Pacific | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BN.PA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
